At the same time, the pathway analysis shows that YFJPT might work on various signal paths which are associated with the pathogenes of Covid-19 including pathways in cancer(hsa05200), IL-17 signaling pathway(ko04657), fluid shear stress and atherosclerosis(ko05418), HIF-1 signaling pathway(hsa04066), nonalcoholic fatty liver disease (hsa04932), and so on. Here, IL17A is linked to metabolic dysfunction-associated steatotic liver disease.